HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Monteiro Selected Research

Therapeutics

3/2014Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
3/2014Quantitative computed tomography-derived clusters: redefining airway remodeling in asthmatic patients.
3/2009Mepolizumab and exacerbations of refractory eosinophilic asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Monteiro Research Topics

Disease

8Asthma (Bronchial Asthma)
02/2024 - 03/2009
3Inflammation (Inflammations)
01/2016 - 02/2013
1Virus Diseases (Viral Diseases)
03/2022
1Chronic Obstructive Pulmonary Disease (COPD)
01/2014
1Cough
12/2010
1Chronic Cough
12/2010
1Bronchitis
07/2009
1Respiratory Hypersensitivity
03/2009

Drug/Important Bio-Agent (IBA)

2mepolizumabIBA
03/2014 - 03/2009
1AllergensIBA
02/2024
1Immunoglobulin E (IgE)IBA
02/2024
1Interleukin-8 (Interleukin 8)IBA
03/2022
1Type II Tumor Necrosis Factor ReceptorsIBA
03/2022
1CytokinesIBA
03/2022
1Interleukin-6 (Interleukin 6)IBA
03/2022
1Biomarkers (Surrogate Marker)IBA
03/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2016
1Levofloxacin (Levaquin)FDA Link
01/2014
1Phenobarbital (Luminal)FDA Link
02/2013
1Fibrinogen (Factor I)FDA Link
02/2013
1Erythromycin (Erycette)FDA LinkGeneric
12/2010
1InterleukinsIBA
07/2009
1Interleukin-13IBA
07/2009
1Bronchodilator Agents (Bronchodilators)IBA
03/2009

Therapy/Procedure

3Therapeutics
03/2014 - 03/2009
1Ambulatory Care (Outpatient Care)
03/2022